The Link Between Melatonin and Heart Health Recent research suggests that melatonin might influence cardiovascular health in more ways than previously understood
The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]
After obtaining count data for the IMSA cohort, the IMSA and SARP count data were processed together
Drinking alcohol, is like adding an accelerator to the crash
From a loss of muscle mass and diminished sexual function to a decline in bone density, it's a condition that demands attention